Updates from The Motley Fool

Latest updates on Navidea Biopharmaceuticals, Inc. from Fool.com.

Stock Performance

NAVB vs. S&P 500 | 2 Year Performance
NAVB 1-Day Stock Chart
NAVB 5-Day Stock Chart
NAVB 1-Month Stock Chart
NAVB 3-Month Stock Chart
NAVB 6-Month Stock Chart
NAVB 1-Year Stock Chart
NAVB 2-Year Stock Chart
NAVB 5-Year Stock Chart
View Interactive NAVB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Navidea Biopharmaceuticals, Inc..
Current Price: $1.42
Prev Close: $1.50
Open: $1.49
Bid: $1.35
Ask: $1.80
Day's Range: $1.42 - $1.51
52wk Range: $0.75 - $2.50
Volume: 648,305
Avg Vol 517,892
Market Cap: $221.09M
P/E (ttm): 7.89
EPS (ttm): $0.19
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Navidea Biopharmaceuticals, Inc..
CAPS Rating 2 out of 5
92 Outperform
19 Underperform
CAPS All Stars
11 Outperform
8 Underperform

How do you think Navidea Biopharmaceuticals, Inc. will perform against the market?

You pick for Navidea Biopharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark J. Pykett, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Navidea Biopharmaceuticals, Inc..

Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Healthcare IT